CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the FDA's approval of the company's non-opioid painkiller pill Journavx, a new ...
Looking for a gentle, feel-good workout to ease pelvic pain and boost circulation? This 40-minute Pilates session with Mira is perfect for fibroids, endometriosis, or period discomfort. Breathe, ...
The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.